x-dc{display:none!important}.nojs-guide{max-width:900px;margin:0 auto;padding:40px 24px;font-family:system-ui,sans-serif;color:#23332d;line-height:1.75;background:#fff}.nojs-guide h1,.nojs-guide h2{color:#164f43}.nojs-guide section{border-top:1px solid #dbe5df;padding:22px 0}.nojs-guide a{color:#164f43;font-weight:700}

Back to MY YL MED

Integrative Oncology and Traditional Chinese Medicine: A Safety-Focused Patient Guide

Traditional Chinese Medicine is a distinct medical tradition. In cancer care, complementary use should be considered alongside, not instead of, surgery, chemotherapy, radiation, targeted therapy, immunotherapy and other standard care.

What this guide covers

This guide explains how integrative oncology is discussed, why evidence must be specific, what herb and supplement interactions can occur, and which questions belong with the local oncology team.

A short historical context

Classical Chinese medical texts include the Yellow Emperor's Inner Canon, Zhang Zhongjing's Treatise on Cold Damage, the major Ming dynasty formularies and Li Shizhen's Compendium of Materia Medica. Historical importance does not, by itself, prove that a formula is effective or safe for a particular cancer treatment.

Terms patients may hear

Common terms include pattern-based individualization, resilience and illness frameworks, traditional circulation concepts, and supportive-care goals such as reducing treatment burden. They are discussion concepts, not guaranteed outcomes or substitutes for measured clinical evidence.

How an integrative consultation is framed

A clinician first reviews the diagnosis, standard treatment, current medicines, laboratory results and the patient's priorities. The consultation may discuss symptoms, nutrition, sleep, fatigue and quality of life. Any later herbal recommendation requires individual clinical and destination-specific review.

Evidence must remain specific

NCCIH, NCI and oncology societies publish guidance for specific complementary approaches. Evidence for one symptom, product or intervention cannot be generalized to every herb, formula, cancer type or individual patient.

Interaction safety

Some herbs and dietary supplements can change how cancer medicines work or cause adverse reactions. A clinician should review the complete medicine list, and the local oncology team should remain informed.

What this service does not claim

It does not replace care from the patient's local medical team, diagnosis, surgery, chemotherapy, radiotherapy, targeted therapy or immunotherapy. It does not promise to control a tumour, boost immunity, remove treatment side effects or cure disease.

Primary references

NCCIH cancer and complementary care guidance · SIO-ASCO oncology pain guideline · NCI cancer therapy and supplement interactions

Next step

Review the cross-border health consultation service, or book the USD $30 doctor video consultation. For a general question before payment, use the contact options on the homepage.

Medical institution: 成都金牛明医云联互联网医院

明医云联本草

{{ t.coverEyebrow }}

{{ t.coverTitle1 }}
{{ t.coverTitle2 }}

{{ t.coverSub }}

{{ t.coverBadge }}

{{ t.scrollHint }}

序 · PROLOGUE

{{ t.proTitle }}

{{ t.proBody }}

{{ t.proYes }}

{{ t.proYesBody }}

{{ t.proNo }}

{{ t.proNoBody }}

第一章 · CHAPTER ONE

{{ t.ch1Title }}

{{ t.ch1Sub }}

{{ e.cn }} {{ e.en }}

{{ e.year }}

{{ e.desc }}

{{ e.detail }}

{{ e.more }}

第二章 · CHAPTER TWO

{{ t.ch2Title }}

{{ t.ch2Sub }}

{{ t.ch2Hint }}

{{ m.cn }}

{{ m.pinyin }}

{{ t.flipWord }}

{{ m.enTitle }}

{{ m.en }}

第三章 · CHAPTER THREE

{{ t.modelTitle }}

{{ t.modelSub }}

Three connected parts of a coordinated care plan

01

{{ t.modelOneTitle }}

{{ t.modelOneBody }}

02

{{ t.modelTwoTitle }}

{{ t.modelTwoBody }}

03

{{ t.modelThreeTitle }}

{{ t.modelThreeBody }}

{{ t.lensesTitle }}

{{ t.lensesBody }}

{{ t.livingTitle }}

{{ t.livingBody }}

{{ t.modelNote }}

第四章 · CHAPTER FOUR

{{ t.ch3Title }}

{{ t.ch3Sub }}

{{ ev.title }}

{{ ev.body }}

“{{ t.ch3Quote }}”

{{ t.ch3Source }}

NCCIH: Cancer and Complementary Health Approaches · SIO–ASCO Oncology Pain Guideline · NCI: Cancer Therapy and Supplement Interactions

第五章 · CHAPTER FIVE

{{ t.ch4Title }}

{{ t.ch4Sub }}

{{ d.title }}

{{ d.body }}

安全
第一

第六章 · CHAPTER SIX

{{ t.ch5Title }}

{{ t.ch5Sub }}

{{ s.title }}

{{ s.body }}

{{ t.ch5Pull }}

终 · BEGIN YOUR CARE

{{ t.ctaTitle }}

{{ t.ctaSub }}

{{ t.ctaBook }} {{ t.ctaBack }}

{{ t.disclaimer }}

{{ t.publisherLine }}